Skip to content

Using the LINE@ Online Platform to Follow Up on Illegal Drug Use Among College and University Students

Using Line@ Online Platform to Follow up on Counseling Intervention Effectiveness for Illegal Drug Use Among College and University Students

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07312591
Enrollment
30
Registered
2025-12-31
Start date
2025-09-01
Completion date
2026-06-30
Last updated
2025-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Illegal Drug Use

Brief summary

This study developed a LINE@ online platform for tracking college and university students involved in illegal drug use, with the aim of evaluating the effectiveness of the intervention.

Detailed description

Effectiveness indicators were collected using a structured questionnaire, including family functioning, severity of substance dependence, motivation for change, and emotional health management. In addition, a structured questionnaire was used to gather university students' user evaluations of the LINE@ online platform.

Interventions

DEVICELINE@ Online Platform Intervention

Using digital learning materials covering family functioning, substance dependence severity, motivation for change, and emotional health management.

Sponsors

National Taiwan Normal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* College students with a history of illegal drug use (confirmed by urine screening or other methods, such as self-reported use, curiosity-driven misuse, or accidental use)

Exclusion criteria

* Younger than 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Family FunctioningTo be completed within 2 months from the start of participation1.Assessment of family dynamics and functioning using using validated scales FAMILY APGAR (questionnaire). 2.The score ranges from 0 to 10, with higher scores indicating better family functioning.
Severity of Substance DependenceTo be completed within 2 months from the start of participation1.Evaluation of the severity of substance dependence among participants using validated scales The Severity of Dependence Scale (questionnaire). 2.The score ranges from 0 to 15, with higher scores indicating a greater level of substance dependence in the participant.
Motivation for ChangeTo be completed within 2 months from the start of participation1.Measurement of participants' motivation to change their substance use using validated scales University of Rhode Island Change Assessment (questionnaire). 2.The score ranges from 2 to 10, with higher scores indicating a greater severity of addictive behaviors and a higher level of motivation to change in the participant's clinical course.
Emotional Health ManagementTo be completed within 2 months from the start of participation1.Assessment of emotional health management skills through using validated scales Brief Symptom Rating Scale (questionnaire). 2.The score ranges from 0 to 20, with higher scores indicating a greater level of emotional distress.
Drug Abuse Screening TestTo be completed within 2 months from the start of participation1.Survey on illegal drug use in the past 1 month using validated scales Drug Abuse Screening Test (questionnaire). 2.The score ranges from 0 to 10, with higher scores indicating a higher risk level of illegal drug use.

Secondary

MeasureTime frameDescription
User Evaluation of the LINE@ Online PlatformTo be completed within 2 months from the start of participation1.Participants' evaluation of the usability and effectiveness of the LINE@ platform using validated scales System usability scale (questionnaire). 2.The score ranges from 0 to 100, with higher scores indicating a higher evaluation of the educational material by the participants.

Countries

Taiwan

Contacts

Primary ContactLi Li, BS
bcfs0340090@gmail.com0912978806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026